TENOFOVIR ALAFENAMIDE for Hepatic cirrhosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 23 adverse event reports in the FDA FAERS database where TENOFOVIR ALAFENAMIDE was used for Hepatic cirrhosis.
Most Reported Side Effects for TENOFOVIR ALAFENAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 217 | 7.3% | 214 | 2 |
| Product dose omission issue | 153 | 5.1% | 4 | 18 |
| Off label use | 96 | 3.2% | 8 | 31 |
| Drug ineffective | 93 | 3.1% | 5 | 13 |
| Fatigue | 92 | 3.1% | 1 | 8 |
| Headache | 71 | 2.4% | 0 | 6 |
| Product dose omission | 69 | 2.3% | 0 | 2 |
| Intentional dose omission | 67 | 2.2% | 0 | 5 |
| Product use issue | 67 | 2.2% | 0 | 6 |
| Nausea | 64 | 2.1% | 1 | 7 |
| Diarrhoea | 60 | 2.0% | 4 | 21 |
| Maternal exposure during pregnancy | 58 | 1.9% | 0 | 4 |
| Foetal exposure during pregnancy | 52 | 1.7% | 7 | 9 |
| Neoplasm malignant | 52 | 1.7% | 9 | 11 |
| Hepatitis b | 48 | 1.6% | 3 | 16 |
Other Indications for TENOFOVIR ALAFENAMIDE
Hepatitis b (935)
Product used for unknown indication (757)
Chronic hepatitis b (679)
Hiv infection (197)
Hepatitis viral (38)
Acute hepatitis b (36)
Antiretroviral therapy (24)
Hepatitis b reactivation (21)
Acquired immunodeficiency syndrome (15)
Viral hepatitis carrier (12)
Other Drugs Used for Hepatic cirrhosis
RIFAXIMIN (1,346)
OMBITASVIR\PARITAPREVIR\RITONAVIR (1,194)
DASABUVIR (1,073)
RIBAVIRIN (1,029)
LEDIPASVIR\SOFOSBUVIR (552)
SOFOSBUVIR\VELPATASVIR (368)
SOFOSBUVIR (345)
GLECAPREVIR\PIBRENTASVIR (184)
DACLATASVIR (140)
TOLVAPTAN (126)